Pharmosa Biopharm Inc. (6875.TWO)
TWD 53.2
(-1.48%)
TWD 53.2
(-1.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 314.5 Million | - | - | - | - |
| Cost of Revenue | - | - | - | - | 9.84 Million |
| Gross Profit | 314.5 Million | - | - | - | -9.84 Million |
| Operating Expenses | 317.32 Million | 271.53 Million | 259.12 Million | 187.41 Million | 129.29 Million |
| Selling, General and Administrative Expenses | 40.35 Million | 29.22 Million | 18.31 Million | 12.11 Million | 9.27 Million |
| Research and Development Expenses | 276.97 Million | 242.31 Million | 240.8 Million | 175.3 Million | 120.02 Million |
| Other Expenses | - | 1.25 Million | 3.09 Million | 4.91 Million | - |
| Cost and Expenses | 317.32 Million | 271.53 Million | 259.12 Million | 187.41 Million | 139.14 Million |
| Operating Income | -2.82 Million | -265.85 Million | -255.26 Million | -177.83 Million | -139.14 Million |
| Interest Expense | 2.85 Million | 649 Thousand | 1.21 Million | 3.85 Million | 2.86 Million |
| Income Tax Expense | - | - | - | - | 15.18 Million |
| Earnings before Tax | 8.45 Million | -266.5 Million | -256.47 Million | -181.69 Million | -128.22 Million |
| Net Income | 8.45 Million | -266.5 Million | -256.47 Million | -181.69 Million | -129.62 Million |
| Earnings Per Share Basic | 0.07 | -2.65 | -2.94 | -3.72 | -1.29 |
| Earnings Per Share Diluted | 0.07 | -2.65 | -2.94 | -3.72 | -1.29 |
| Weighted Average Shares Outstanding | 113.22 Million | 100.74 Million | 87.13 Million | 48.8 Million | 100.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 113.39 Million | 100.74 Million | 87.13 Million | 48.8 Million | 100.58 Million |
| Gross Margin | 1.00 | - | - | - | - |
| EBIT Margin | 0.09 | - | - | - | - |
| Profit Margin | 0.03 | - | - | - | - |
| EBITDA | 29.13 Million | -257.08 Million | -244.12 Million | -171.84 Million | -115.51 Million |
| Earnings Before Tax Margin | -0.01 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 9.54 Million | 75 Thousand | - | 314.5 Million | 314.5 Million | - |
| Cost of Revenue | 6.82 Million | 65 Thousand | - | - | - | - |
| Gross Profit | 2.71 Million | 10 Thousand | - | 314.5 Million | 314.5 Million | - |
| Operating Expenses | 73.74 Million | 69.7 Million | 90.01 Million | 317.32 Million | 93.61 Million | 69.72 Million |
| Selling, General and Administrative Expenses | 11.6 Million | 17.44 Million | 12.76 Million | - | 11.03 Million | 9.57 Million |
| Research and Development Expenses | 62.14 Million | 52.26 Million | 77.25 Million | - | 82.58 Million | 60.15 Million |
| Other Expenses | 4.17 Million | 11.49 Million | -8.22 Million | -892 Thousand | 7.7 Million | -402 Thousand |
| Cost and Expenses | 80.56 Million | 69.76 Million | 90.01 Million | 317.32 Million | 93.61 Million | 69.72 Million |
| Operating Income | -58.03 Million | -52.28 Million | -90.13 Million | 11.31 Million | 231.7 Million | -66.82 Million |
| Interest Expense | 574 Thousand | 638 Thousand | 1.21 Million | 2.85 Million | 1.05 Million | 474 Thousand |
| Income Tax Expense | - | - | - | - | - | - |
| Earnings before Tax | -58.6 Million | -52.92 Million | -91.35 Million | 8.45 Million | 230.65 Million | -67.29 Million |
| Net Income | -58.6 Million | -52.92 Million | -91.35 Million | 8.45 Million | 230.65 Million | -67.29 Million |
| Earnings Per Share Basic | -0.45 | -0.45 | -0.78 | - | 2.03 | -0.61 |
| Earnings Per Share Diluted | -0.45 | -0.45 | -0.78 | - | 2.03 | -0.61 |
| Weighted Average Shares Outstanding | 130.24 Million | 117.6 Million | 116.81 Million | 113.22 Million | 113.62 Million | 110.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 130.24 Million | 117.6 Million | 117.24 Million | 113.39 Million | 113.62 Million | 110.31 Million |
| Gross Margin | 0.28 | 0.13 | - | 1.00 | 1.00 | - |
| EBIT Margin | -5.46 | -620.45 | - | - | 0.76 | - |
| Profit Margin | -6.14 | -705.60 | - | 0.03 | 0.73 | - |
| EBITDA | -52.12 Million | -46.53 Million | -82.18 Million | - | 238.89 Million | -61.99 Million |
| Earnings Before Tax Margin | -6.08 | -697.09 | - | 0.04 | 0.74 | - |
3131
2062
4106
WISE
5272
9845